24 June 2020

How divestments can offer renewed growth for life sciences companies

As a whole, the life sciences industry is in a strong position to withstand the financial pressures and successfully navigate through the economic slowdown just as it has done in the past three recessions. The COVID-19 pandemic has tested — and will continue to test — the resiliency of life sciences companies. An EY article provides details.

Document ID: 2020-5912